Form N-CEN OneAscent Capital Opport For: Mar 31
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Breakthrough T1D Celebrates Approval of Tzield for use in Stage 3 Type 1 Diabetes in the US
- CoreAge Rx Earns Strong Patient Reviews on Trustpilot, Expanding Care with New Wellness Community for Weight Management
- CoreAge Rx Achieves Top Trustpilot Ratings as Patients Praise Fast Delivery, Support, and Success in Weight Management
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
